Skip to main content
Article thumbnail
Location of Repository

Evaluation of Sphingolipids in Wistar Rats Treated to Prolonged and Single Oral Doses of Fumonisin B1

By Glória M. Direito, Adriana P. Almeida, Simone Aquino, Tatiana Alves dos Reis, Claudia Rodrigues Pozzi and Benedito Corrêa

Abstract

The objective of the present study was to evaluate sphingolipid levels (sphingosine-So and sphinganine-Sa) and to compare the Sa/So ratio in liver, serum and urine of Wistar rats after prolonged administration (21 days) of fumonisin B1 (FB1). In parallel, the kinetics of sphingolipid elimination in urine was studied in animals receiving a single dose of FB1. Prolonged exposure to FB1 caused an increase in Sa levels in urine, serum and liver. The most marked effect on sphingolipid biosynthesis was observed in animals treated with the highest dose of FB1. Animals receiving a single dose of FB1 presented variations in Sa and So levels and in the Sa/So ratio

Topics: Article
Publisher: Molecular Diversity Preservation International (MDPI)
OAI identifier: oai:pubmedcentral.nih.gov:2662460
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2001). An overview of rodent toxicities: Liver and kidney effects of fumonisins and Fusarium moniliforme. Environ. Health Perspect.
    2. (1998). Analytical method for the determination of sphinganine and sphingosine in serum as a potential biomarker for fumonisin exposure.
    3. (2007). Biomarkers of exposure to fumonisin mycotoxins: A review. Food Addit. Contam.
    4. (2002). Carcinogenicity and mechanism of action of fumonisin B1: a mycotoxin produced by Fusarium moniliforme
    5. (1996). Development of a new method for the analysis of sphinganine and sphingosine in urine and tissues.
    6. (1994). Dietary fumonisin B1 induces disruption of sphingolipid metabolism in Sprague-Dawley rats: A new mechanism of nephrotoxicity.
    7. (2006). Differential sensitivity of rat kidney and liver to fumonisin toxicity: Organ-specific differences in toxin accumulation and sphingoid base metabolism.
    8. (2000). Disruption of sphingolipid metabolism in small intestines, liver and kidney of mice dosed subcutaneously with fumonisin B1. Food Chem. Toxicol.
    9. (1997). Effects of intravenous Fumonisin B1 in rabbits: Nephrotoxicity and sphingolipid alterations.
    10. (2000). Effects of prolonged oral administration of fumonisin B1 and aflatoxin B1 in rats. Mycopathologia
    11. (1996). Evidence for disruption of sphingolipid metabolism as a contributing factor in the toxicity and carcinogenicity of fumonisins.
    12. (1995). Fate of a single dose of 14C-labeled fumonisin B1 in vervet monkeys.
    13. (1993). for Research on Cancer (IARC). Toxins Derived from Fusarium Moniliforme: Fumonisins
    14. (1992). Fumonisin B1 production by Fusarium species other than F. moniliforme in Section Liseola a by some related species.
    15. (1999). Fumonisin contamination of food progress in development of biomarkers to better assess human health risks.
    16. (1996). Fumonisin Toxicity and Sphingolipid Biosynthesis.
    17. (1992). Fumonisin toxicity in broiler chicks.
    18. (1988). Fumonisins — Novel mycotoxins with cancer promotion activity produced by Fusarium moniliforme.
    19. (1998). Fumonisins: Mechanism of mycotoxicity. Revue Méd. Vét.
    20. (1992). Fusarium moniliforme and fumonisins in corn in relation to human esophageal cancer in Transkei. Phytopathology
    21. (2001). High-performance liquid chromatographic determination of sphinganine and sphingosine in serum and urine of subjects from an endemic nephropathy area in
    22. (2000). In vitro and in vivo studies to assess the effectiveness of cholestiramine as a binding agent for fumonisins. Mycopathologia
    23. (1998). In vivo effects of fumonisin B1- producing and fumonisin B1- nonproducing Fusarium moniliforme isolates are similar: Fumonisins B2 and B3 cause hepato and nephrotoxicity in rats. Mycopathologia,
    24. (1992). Increase in serum sphingosine and sphinganine and decrease in complex sphingolipids in ponies given feed containing fumonisins, mycotoxins produced by Fusarium
    25. (1988). Leukoencephalomalacia in horse induced by fumonisin B1 isolated from Fusarium moniliforme. Onderstepoort
    26. (1990). Leukoencephalomalacia in two horses induced by oral dosing of fumonisin B1. Onderstepoort
    27. (1996). Liquid Chromatographic determination of fumonisins B1, B2 and B3 in corn.
    28. (1994). Liquid chromatographic determination of sphinganine and sphingosine: Use of the free sphinganine-to-sphingosine ratio as a biomarker for consumption of fumonisins.
    29. (1998). Liquid chromatographic determination of the sphinganine/sphingosine ratio in
    30. (2005). Mechanism of action of sphingolipids and their metabolites in the toxicity of fumonisin B1. Progr. Lipids Res.
    31. (2001). metabolism and impact of mycotoxin on humans and animals. Toxicology
    32. (1990). Natural occurrence of some Fusarium mycotoxins in corn from low and high esophageal cancer prevalence areas of the Transkei,
    33. (2006). Serum sphinganine and the sphinganine to sphingosine ratio as a biomarker of dietary fumonisins during chronic exposure in ducks.
    34. (2003). Shinganine to sphingosine ratio and predictive biochemical markers of fumonisin B1 exposure in ducks.
    35. (2001). Sphingolipid perturbation as mechanism for fumonisin carcinogenesis. Environ. Health Perspect.
    36. (1997). Sphingolipids — The enigmatic lipid class;
    37. (2000). Sphingosine-1-phosphate: signaling inside and out.
    38. (1995). Subchronic feeding study of the mycotoxin fumonisin
    39. (1989). Survey of aflatoxins, ochratoxin A, zearalenone and sterigmatocystin in some Brazilian foods by using multitoxin thin layer chromatographic method.
    40. (2001). The effect of a single gavage dose of fumonisin B2 on the sphinganine and sphingosine concentrations in vervet monkeys. Food Chem. Toxicol.
    41. (2001). The induction and persistence of altered sphingolipid biosynthesis in rats treated with fumonisinB1. Food Addit. Contam.
    42. (1996). The Mycotoxin Fumonisin Induces Apoptosis in Cultures Human Cells and Livers and Kidneys of Rats.
    43. (1999). Time course dependence, and reversibility of increases in urinary sphinganine and sphingosine in animals fed defined diets containing fumonisin B1: Characteristics of urinary biomarkers for exposure to fumonisins.
    44. (2001). Tissue sphinganine as a biomarker of fumonisin-induced apoptosis. Food Addit. Contam.
    45. (1997). Toxicity of fumonisin B1 to B6C3F1 mice: A 14 day gavage study. Food Chem. Toxicol.
    46. (1999). Toxicokinetics and oral bioavailability of fumonisin B1.Vet.
    47. (2001). Toxicological effects in rats chronically fed low dietary levels of fumonisin B1. Toxicology
    48. (2003). Toxicological effects of chronic low doses of aflatoxin B1 and fumonisin B1 containing Fusarium moniliforme culture material in weaned piglets. Food Chem. Toxicol.
    49. (2007). Validation of fumonisin biomarkers in F344 rats.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.